EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 28 filers reported holding EVOKE PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $26,000 | -27.8% | 14,000 | 0.0% | 0.00% | – |
| Q4 2020 | $36,000 | -45.5% | 14,000 | 0.0% | 0.00% | – |
| Q3 2020 | $66,000 | +20.0% | 14,000 | -10.1% | 0.00% | – |
| Q2 2020 | $55,000 | +205.6% | 15,566 | 0.0% | 0.00% | – |
| Q1 2020 | $18,000 | -28.0% | 15,566 | 0.0% | 0.00% | – |
| Q4 2019 | $25,000 | +92.3% | 15,566 | 0.0% | 0.00% | – |
| Q3 2019 | $13,000 | +30.0% | 15,566 | 0.0% | 0.00% | – |
| Q2 2019 | $10,000 | -56.5% | 15,566 | 0.0% | 0.00% | – |
| Q1 2019 | $23,000 | -41.0% | 15,566 | 0.0% | 0.00% | – |
| Q4 2018 | $39,000 | -15.2% | 15,566 | 0.0% | 0.00% | – |
| Q3 2018 | $46,000 | +17.9% | 15,566 | 0.0% | 0.00% | – |
| Q2 2018 | $39,000 | +21.9% | 15,566 | 0.0% | 0.00% | – |
| Q1 2018 | $32,000 | -8.6% | 15,566 | 0.0% | 0.00% | – |
| Q4 2017 | $35,000 | -32.7% | 15,566 | 0.0% | 0.00% | – |
| Q3 2017 | $52,000 | +30.0% | 15,566 | 0.0% | 0.00% | – |
| Q2 2017 | $40,000 | – | 15,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,433,113 | $2,623,000 | 0.55% |
| Worth Venture Partners, LLC | 336,516 | $616,000 | 0.30% |
| Wambolt & Associates, LLC | 32,000 | $59,000 | 0.03% |
| Pure Financial Advisors, LLC | 17,647 | $32,000 | 0.00% |
| OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,540 | $6,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 179 | $0 | 0.00% |
| NORTHERN TRUST CORP | 42,121 | $77,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 16,101 | $29,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 159,979 | $292,000 | 0.00% |